Sponsor study identifier
observational
200
1 country
1
Study Start
August 5, 2019
Actual (reported)Primary Completion
June 1, 2023
Actual (reported)Study Completion
June 1, 2023
Actual (reported)The objective of this study is to further evaluate eye movements as an aid in the diagnosis of concussion / mTBI and the utility of eye movement assessment in the monitoring of symptoms over time after an initial diagnosis of concussion.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 1, 2023
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 22, 2019
Actual (reported)May 29, 2019
Actual (reported)August 5, 2019
Actual (reported)June 1, 2023
Actual (reported)June 1, 2023
Actual (reported)diagnostic accuracy of initial clinical diagnosis of concussion
sensitivity and specificity compared to initial clinical diagnosis of concussion
day 0 (when patient first presents for evaluation)
diagnostic accuracy of clinical diagnosis of post-concussion symptoms
sensitivity and specificity compared to clinical diagnosis of post-concussion symptoms
up to one year after initial presentation
adverse events
adverse events occurring during use of the diagnostic device
through study participation, up to one year
diagnostic accuracy of initial clinical diagnosis of concussion
day 0 (when patient first presents for evaluation)
correlation with increases or decreases in post-concussion symptom severity
up to one year after initial presentation
The EyeBOX medical device tracks a patient's eye movement and calculates a BOX Score ranging from 0-20. The BOX score is interpreted as a binary classification for eye movement abnormalities, where anything equal to or greater than 10 is a positive result for the initial evaluation of concussion and everything below 10 is negative.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
All consecutive subjects who meet all of the inclusion criteria and none of the exclusion criteria
New York Sports Medicine Institute
White Plains, New York, 10604, United States
Rosina Samadani, PhD
Oculogica, Inc.
200 participants (actual enrollment reported by the registry).
First Submitted
May 22, 2019
First Posted
May 29, 2019
Study Start
August 5, 2019
Actual (reported)Risk Stratification in Children With Concussion
Contact the study team to confirm eligibility.
Primary Completion
June 1, 2023
Actual (reported)Study Completion
June 1, 2023
Actual (reported)Last Updated
September 7, 2023
Record last verified: 2023-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: